We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

All-In-One CLIA Analyzer to Transform Clinical Diagnostics Landscape

By LabMedica International staff writers
Posted on 12 Jul 2023
Print article
Image: The ADL i1910 CLIA analyzer is designed for comprehensive clinical testing (Photo courtesy of Anbio)
Image: The ADL i1910 CLIA analyzer is designed for comprehensive clinical testing (Photo courtesy of Anbio)

An automated, compact, and cost-effective CLIA analyzer combines cutting-edge technology with versatile capabilities to provide a wide range of qualitative and quantitative testing options for analytes in human serum, plasma, whole blood, and urine samples.

Anbio Biotechnology (Frankfurt, Germany) has launched the Anbio ADL i1910 all-in-one CLIA analyzer that employs a direct chemiluminescence method based on acridinium ester. This ensures accurate and consistent results across a wide range of applications, including hormone detection, myocardial disease screening, infectious disease diagnostics, or tumor-related antigen analysis. The ADL i1910 delivers a powerful performance and fulfills the varied requirements of modern healthcare professionals. It offers an impressive range of 49 developed assays, enabling qualitative as well as quantitative testing of analytes. The ADL i1910 provides a comprehensive immunodiagnostic solution for healthcare providers to access vital information in an efficient manner.

The ADL i1910 significantly enhances laboratory productivity, thanks to its high throughput of up to 120 tests per hour. With its quick turnaround times, healthcare providers can arrive at timely and informed decisions, eventually improving patient care. Its intuitive graphic user interface coupled with a large color touch screen simplifies operation and shortens the learning curve. It user-friendly design makes it easy to use for experienced professionals and new users alike, thus improving overall efficiency. Designed to occupy minimal space, the ADL i1910 has a small footprint in order to optimize valuable space for other necessary lab equipment, making it ideal for laboratories of all sizes. By offering healthcare providers a cost-effective and comprehensive solution, the Anbio ADL i1910 is expected to transform the clinical diagnostics space.

"Anbio is proud to introduce the ADL i1910, a breakthrough CLIA analyzer that revolutionizes clinical diagnostics," said Jack Davis, Chief Business Officer at Anbio. "With its advanced technology, extensive assay menu, and impressive throughput, the ADL i1910 provides healthcare professionals with a reliable and efficient solution for a wide range of diagnostic applications."

Related Links:
Anbio Biotechnology 

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.